11/12/2017 - 07:18 StockMarketWire
IXICO saw robust revenue growth in the year to the end of September strengthened by the entry into a number of new co...
11/12/2017 - 07:00 RNS
Announcement of full year/4th quarter financial results
28/11/2017 - 07:00 RNS
16/11/2017 - 08:20 StockMarketWire
IXICO has signed a new contract with another leading biopharmaceutical company to support the use of wrist worn activ...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment